31.07.2025
EUCAST to review carbapenem breakpoints
EUCAST aims to review breakpoints for carbapenems, alone and in combination with inhibitors. Anyone with data to support a breakpoint process are invited to highlight and submit relevant evidence. At the end of the EUCAST process, we will invite colleagues to participate in the consultation process prior to a final decision.
